Identification and validation of the TRHDE‐AS1/hsa‐miR‐449a/ADAMTS5 axis as a novel prognostic biomarker in prostate cancer

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Integrated Analysis of a ceRNA (lncRNA-miRNA-mRNA) Regulatory Network for Prostate Cancer2024
2. 2Unveiling four axes ADAMTS9-AS2|MEG3/hsa-miR-150/PRKCA|MMP14 within prostate cancer through establishment of the ceRNA network2024 · 1 citations
3. 3Systematic characterization of cross-source miRNA biomarkers in prostate cancer with computational-experimental integrated analysis2025
4. 448P CAF-specific targeting uncovered by patient-derived models synergistically restrains pancreatic tumor progression and chemoresistance2026
5. 5In silico Identification of microRNAs Differentially Expressed in Prostate Cancer and Related to Tumor Aggressiveness2026 · 2 citations